$ICAD
ICAD INC Stock $icad

$icad Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000119312513326953 Filed on August 08, 2013

Income Statement

Concept	2013 Q2	2012 Q2
Revenue	$7.712M	$5.931M
YoY Change	30.03%	-10.81%
Cost Of Revenue	$2.490M	$1.762M
YoY Change	41.32%	-17.66%
Gross Profit	$5.222M	$4.169M
YoY Change	25.26%	-7.36%
Gross Profit Margin	67.71%	70.29%
Selling, General & Admin	$3.939M	$4.091M
YoY Change	-3.72%	-44.42%
% of Gross Profit	75.43%	98.13%
Research & Development	$1.756M	$1.975M
YoY Change	-11.09%	-40.15%
% of Gross Profit	33.63%	47.37%
Depreciation & Amortization	$620.0K	$760.0K
YoY Change	-18.42%	-2.56%
% of Gross Profit	11.87%	18.23%
Operating Expenses	$5.695M	$6.066M
YoY Change	-6.12%	-43.1%
Operating Profit	-$473.0K	-$1.897M
YoY Change	-75.07%	-69.2%
Interest Expense	$834.0K	$831.0K
YoY Change	0.36%	-931.0%
% of Operating Profit
Other Income/Expense, Net	-$1.399M	-$1.035M
YoY Change	35.17%
Pretax Income	-$1.872M	-$2.932M
YoY Change	-36.15%	-45.8%
Income Tax	$10.00K	$11.00K
% Of Pretax Income
Net Earnings	-$1.882M	-$2.943M
YoY Change	-36.05%	-45.6%
Net Earnings / Revenue	-24.4%	-49.62%
Basic Earnings Per Share	-$0.17	-$0.27
Diluted Earnings Per Share	-$0.17	-$0.27
COMMON SHARES
Basic Shares Outstanding	10.84M shares	10.79M shares
Diluted Shares Outstanding	10.84M shares	10.79M shares

Balance Sheet

Concept	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.91M	$14.26M
YoY Change	-9.47%	85.68%
Cash & Equivalents	$12.91M	$14.26M
Short-Term Investments
Other Short-Term Assets	$470.0K	$860.0K
YoY Change	-45.35%	45.76%
Inventory	$1.941M	$1.960M
Prepaid Expenses
Receivables	$6.099M	$3.330M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$21.42M	$20.42M
YoY Change	4.89%	39.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.343M	$1.630M
YoY Change	-17.61%	-30.93%
Goodwill	$21.11M
YoY Change
Intangibles	$14.39M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$530.0K	$820.0K
YoY Change	-35.37%	34.43%
Total Long-Term Assets	$37.37M	$39.57M
YoY Change	-5.56%	-42.43%
TOTAL ASSETS
Total Short-Term Assets	$21.42M	$20.42M
Total Long-Term Assets	$37.37M	$39.57M
Total Assets	$58.79M	$59.99M
YoY Change	-2.0%	-28.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.480M	$1.390M
YoY Change	78.42%	-41.1%
Accrued Expenses	$3.370M	$4.110M
YoY Change	-18.0%	-17.64%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$14.96M	$11.80M
YoY Change	26.81%	-7.01%
LONG-TERM LIABILITIES
Long-Term Debt	$15.17M	$14.42M
YoY Change	5.2%
Other Long-Term Liabilities	$1.248M	$2.490M
YoY Change	-49.88%	-59.97%
Total Long-Term Liabilities	$1.248M	$16.91M
YoY Change	-92.62%	171.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.96M	$11.80M
Total Long-Term Liabilities	$1.248M	$16.91M
Total Liabilities	$33.16M	$28.71M
YoY Change	15.48%	51.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$139.1M
YoY Change
Common Stock	$166.1M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.415M
YoY Change
Treasury Stock Shares	185.8K shares
Shareholders Equity	$25.64M	$31.28M
YoY Change
Total Liabilities & Shareholders Equity	$58.79M	$59.99M
YoY Change	-2.0%	-28.07%

Cashflow Statement

Concept	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	-$1.882M	-$2.943M
YoY Change	-36.05%	-45.6%
Depreciation, Depletion And Amortization	$620.0K	$760.0K
YoY Change	-18.42%	-2.56%
Cash From Operating Activities	$450.0K	-$460.0K
YoY Change	-197.83%	-86.63%
INVESTING ACTIVITIES
Capital Expenditures	-$190.0K	-$250.0K
YoY Change	-24.0%	66.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$190.0K	-$250.0K
YoY Change	-24.0%	66.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-10.00K	-10.00K
YoY Change	0.0%	-66.67%
NET CHANGE
Cash From Operating Activities	450.0K	-460.0K
Cash From Investing Activities	-190.0K	-250.0K
Cash From Financing Activities	-10.00K	-10.00K
Net Change In Cash	250.0K	-720.0K
YoY Change	-134.72%	-80.11%
FREE CASH FLOW
Cash From Operating Activities	$450.0K	-$460.0K
Capital Expenditures	-$190.0K	-$250.0K
Free Cash Flow	$640.0K	-$210.0K
YoY Change	-404.76%	-93.62%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10850244	shares
CY2011Q1	us-gaap	Loss Contingency Range Of Possible Loss Minimum LossContingencyRangeOfPossibleLossMinimum	14500000
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14262000
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	500
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10836911	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11022742	shares
CY2013Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.19	pure
CY2013Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	85000000	shares
CY2013Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	185831	shares
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2013Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	3.50
CY2013Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2013Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3947000
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2480000
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14963000
CY2013Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1248000
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	25635000
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	165995000
CY2013Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2013Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	73000
CY2013Q2	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1678000
CY2013Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2829000
CY2013Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	0
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-139055000
CY2013Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	7433000
CY2013Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11604000
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	110000
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	58790000
CY2013Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	15169000
CY2013Q2	us-gaap	Liabilities Liabilities	33155000
CY2013Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1775000
CY2013Q2	us-gaap	Interest Payable Current InterestPayableCurrent	543000
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q2	us-gaap	Assets Current AssetsCurrent	21419000
CY2013Q2	us-gaap	Goodwill Goodwill	21109000
CY2013Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	531000
CY2013Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14388000
CY2013Q2	us-gaap	Assets Assets	58790000
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12912000
CY2013Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6099000
CY2013Q2	us-gaap	Inventory Net InventoryNet	1941000
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	467000
CY2013Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1836261
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	2968000
CY2013Q2	us-gaap	Treasury Stock Value TreasuryStockValue	1415000
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1343000
CY2013Q2	icad	Litigation And Settlement Obligation Due With In Three Year LitigationAndSettlementObligationDueWithInThreeYear	500000
CY2013Q2	icad	Royalty Obligation Non Current RoyaltyObligationNonCurrent	600000
CY2013Q2	icad	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	450000	shares
CY2013Q2	icad	Litigation And Settlement Obligation LitigationAndSettlementObligation	1000000
CY2013Q2	icad	Litigation And Settlement Obligation Due With In Five Year LitigationAndSettlementObligationDueWithInFiveYear	500000
CY2013Q2	icad	Fair Value Of Warrants FairValueOfWarrants	1678000
CY2013Q2	icad	Minimum Royalty Obligations MinimumRoyaltyObligations	756000
CY2013Q2	icad	Fair Value Of Patent License FairValueOfPatentLicense	100000
CY2011Q4	us-gaap	Litigation Reserve LitigationReserve	1800000
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4576000
CY2012Q1	icad	Gross Proceeds From Transactions GrossProceedsFromTransactions	15000000
CY2012Q1	icad	Net Proceeds Received From Transactions NetProceedsReceivedFromTransactions	14325000
CY2012Q1	icad	Facility Fee Related To Transactions FacilityFeeRelatedToTransactions	225000
CY2012Q1	icad	Finder Fee Related To Transactions FinderFeeRelatedToTransactions	450000
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10808102	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10993933	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	85000000	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	185831	shares
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q4	us-gaap	Assets Current AssetsCurrent	21533000
CY2012Q4	us-gaap	Goodwill Goodwill	21109000
CY2012Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	638000
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3627000
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1940000
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14639000
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1341000
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	27665000
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	165416000
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	48000
CY2012Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1538000
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4142000
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-136446000
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6520000
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10744000
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	110000
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59993000
CY2012Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	14846000
CY2012Q4	us-gaap	Liabilities Liabilities	32328000
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1502000
CY2012Q4	us-gaap	Interest Payable Current InterestPayableCurrent	499000
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15230000
CY2012Q4	us-gaap	Assets Assets	59993000
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13948000
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4980000
CY2012Q4	us-gaap	Inventory Net InventoryNet	2119000
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	486000
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1415000
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1483000
CY2012Q4	icad	Fair Value Of Warrants FairValueOfWarrants	1538000
	dei	Entity Registrant Name EntityRegistrantName	ICAD INC
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2013-06-30
	dei	Entity Central Index Key EntityCentralIndexKey	0000749660
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	Segment
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10828000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	10828000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.14
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.25
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-721000
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.24
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y1M13D
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10828000	shares
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-178000
	us-gaap	Sales Revenue Net SalesRevenueNet	15642000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2180377	shares
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	274000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	140000
	us-gaap	Other Income OtherIncome	12000
	us-gaap	Net Income Loss NetIncomeLoss	-2609000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-37000
	us-gaap	Gross Profit GrossProfit	10870000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2589000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	9564000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1788000
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	12000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	33000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-801000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	19000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-49000
	us-gaap	Interest Paid InterestPaid	1052000
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	6078000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1154000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3274000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-22000
	us-gaap	Cost Of Services CostOfServices	1504000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4772000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2801000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1185000
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	860000
	us-gaap	Share Based Compensation ShareBasedCompensation	601000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	35000
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	1888000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4775000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1036000
	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	271000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1513000
	us-gaap	Interest Expense InterestExpense	1660000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	541000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-293000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3622000
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1096000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	412000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	467000
	us-gaap	Depreciation Depreciation	365000
	us-gaap	Operating Expenses OperatingExpenses	11671000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	323000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20000
	icad	Amount Of Revenue Under Condition Two AmountOfRevenueUnderConditionTwo	25 to 50
	icad	Interest Expense Non Operating InterestExpenseNonOperating	1660000
	icad	Amortization Of Settlement Obligations AmortizationOfSettlementObligations	152000
	icad	Period Of Libor Rate PeriodOfLiborRate	P6Y
	icad	Number Of Year Subject To Examination NumberOfYearSubjectToExamination	P3Y
	icad	Warrants Fair Value Adjustments WarrantsFairValueAdjustments	140000
	icad	Amortization Of Debt Costs AmortizationOfDebtCosts	89000
	icad	Amount Of Revenue Under Condition Three AmountOfRevenueUnderConditionThree	50 and Above
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.40
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4348000
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.48
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10785000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1728301	shares
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1000
	us-gaap	Gross Profit GrossProfit	8596000
	icad	Amount Of Revenue Under Condition One AmountOfRevenueUnderConditionOne	25 and Less
	icad	Minimum Annual Royalty Payment MinimumAnnualRoyaltyPayment	250000
	icad	Year Till Revenue Is Payable Under Revenue Purchase Agreement YearTillRevenueIsPayableUnderRevenuePurchaseAgreement	2017
	icad	Taxes Paid Related To Restricted Stock Issuance TaxesPaidRelatedToRestrictedStockIssuance	25000
	icad	Segment Operating Income Loss SegmentOperatingIncomeLoss	2473000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10785000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	10785000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.80
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5185000
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	7587000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1262000
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	18000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	17000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3923000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-67000
	us-gaap	Interest Paid InterestPaid	485000
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	4687000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-669000
	us-gaap	Other Income OtherIncome	18000
	us-gaap	Net Income Loss NetIncomeLoss	-5207000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-80000
	us-gaap	Sales Revenue Net SalesRevenueNet	12274000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	275000
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-386000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3198000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14312000
	us-gaap	Cost Of Services CostOfServices	1137000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3678000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2076000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-223000
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1046000
	us-gaap	Share Based Compensation ShareBasedCompensation	448000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	859000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	9686000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5134000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2291000
	us-gaap	Interest Expense InterestExpense	1666000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	268000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-278000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4187000
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	952000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	498000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	14325000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	465000
	us-gaap	Depreciation Depreciation	466000
	us-gaap	Operating Expenses OperatingExpenses	12519000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	416000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	22000
	icad	Interest Expense Non Operating InterestExpenseNonOperating	1666000
	icad	Amortization Of Settlement Obligations AmortizationOfSettlementObligations	216000
	icad	Amortization Of Debt Costs AmortizationOfDebtCosts	82000
	icad	Taxes Paid Related To Restricted Stock Issuance TaxesPaidRelatedToRestrictedStockIssuance	13000
	icad	Segment Operating Income Loss SegmentOperatingIncomeLoss	-725000
CY2012	icad	Number Of Patients Treated Using Axxent Flexishield Mini As Part Of Clinical Trial NumberOfPatientsTreatedUsingAxxentFlexishieldMiniAsPartOfClinicalTrial	29	Patient
CY2012	icad	Acquired Patent License Weighted Average Useful Life AcquiredPatentLicenseWeightedAverageUsefulLife	P6Y
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10794000	shares
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2012Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	10794000	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.35
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.15
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10794000	shares
CY2012Q2	us-gaap	Gross Profit GrossProfit	4169000
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2932000
CY2012Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3536000
CY2012Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1035000
CY2012Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	9000
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1897000
CY2012Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	2395000
CY2012Q2	us-gaap	Other Income OtherIncome	9000
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-2943000
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	5931000
CY2012Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	213000
CY2012Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1603000
CY2012Q2	us-gaap	Cost Of Services CostOfServices	560000
CY2012Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1762000
CY2012Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	969000
CY2012Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2488000
CY2012Q2	us-gaap	Interest Expense InterestExpense	831000
CY2012Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1975000
CY2012Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	467000
CY2012Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	233000
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	6066000
CY2012Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	218000
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11000
CY2012Q2	icad	Interest Expense Non Operating InterestExpenseNonOperating	831000
CY2012Q2	icad	Amortization Of Settlement Obligations AmortizationOfSettlementObligations	104000
CY2012Q2	icad	Amortization Of Debt Costs AmortizationOfDebtCosts	42000
CY2012Q2	icad	Segment Operating Income Loss SegmentOperatingIncomeLoss	-294000
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10836000	shares
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2013Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	10836000	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.08
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.12
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10836000	shares
CY2013Q2	us-gaap	Gross Profit GrossProfit	5222000
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1872000
CY2013Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	4504000
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1399000
CY2013Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	6000
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-473000
CY2013Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	3208000
CY2013Q2	us-gaap	Other Income OtherIncome	6000
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-1882000
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	7712000
CY2013Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	571000
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1602000
CY2013Q2	us-gaap	Cost Of Services CostOfServices	810000
CY2013Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2490000
CY2013Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1446000
CY2013Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2337000
CY2013Q2	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	134000
CY2013Q2	us-gaap	Interest Expense InterestExpense	834000
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1756000
CY2013Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	543000
CY2013Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2013Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	234000
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	5695000
CY2013Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	169000
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10000
CY2013Q2	icad	Interest Expense Non Operating InterestExpenseNonOperating	834000
CY2013Q2	icad	Amortization Of Settlement Obligations AmortizationOfSettlementObligations	77000
CY2013Q2	icad	Amortization Of Debt Costs AmortizationOfDebtCosts	45000
CY2013Q2	icad	Segment Operating Income Loss SegmentOperatingIncomeLoss	1129000

Files In Submission

Name	View Source	Status
0001193125-13-326953-index-headers.html	Edgar Link	pending
0001193125-13-326953-index.html	Edgar Link	pending
0001193125-13-326953.txt	Edgar Link	pending
0001193125-13-326953-xbrl.zip	Edgar Link	pending
d548541d10q.htm	Edgar Link	pending
d548541dex31.htm	Edgar Link	pending
d548541dex311.htm	Edgar Link	pending
d548541dex312.htm	Edgar Link	pending
d548541dex321.htm	Edgar Link	pending
d548541dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
g548541ex3a_pg002.jpg	Edgar Link	pending
g548541ex3a_pg004a.jpg	Edgar Link	pending
g548541ex3a_pg004b.jpg	Edgar Link	pending
g548541ex3a_pg006a.jpg	Edgar Link	pending
g548541ex3a_pg006b.jpg	Edgar Link	pending
g548541ex3a_pg007a.jpg	Edgar Link	pending
g548541ex3a_pg007b.jpg	Edgar Link	pending
g548541ex3a_pg011a.jpg	Edgar Link	pending
g548541ex3a_pg011b.jpg	Edgar Link	pending
g548541ex3a_pg015.jpg	Edgar Link	pending
g548541ex3a_pg023.jpg	Edgar Link	pending
g548541ex3a_pg042.jpg	Edgar Link	pending
icad-20130630.xml	Edgar Link	completed
icad-20130630.xsd	Edgar Link	pending
icad-20130630_cal.xml	Edgar Link	unprocessable
icad-20130630_def.xml	Edgar Link	unprocessable
icad-20130630_lab.xml	Edgar Link	unprocessable
icad-20130630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICAD
ICAD INC Stock $icad

2013 Q2 Form 10-Q Financial Statement

#000119312513326953 Filed on August 08, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICAD ICAD INC Stock $icad

2013 Q2 Form 10-Q Financial Statement

#000119312513326953 Filed on August 08, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICAD
ICAD INC Stock $icad